MD, Cardiology Resident 🫀🩺 EP-Fellow
Joined July 2020
- Tweets32
- Following88
- Followers10
- Likes51
Angelo Melpignano retweeted
SMARTBrugada study: Smartwatch Marginosternal Application for Recording Type I Brugada Pattern #OpenAccess
@MelpAngelo
heartrhythmjournal.com/artic…
Angelo Melpignano retweeted
Unravelling the enigmatic morphology of the atrioventricular conduction axis using Hierarchical Phase-Contrast Tomography (HiP-CT) #OpenAccess
@Chloe_Li_ @aaalmehandi @UCL_ICS
heartrhythmjournal.com/artic…
Angelo Melpignano retweeted
facebook.com/share/p/1D4xKzZ…
🧠Master conduction-coronary link!🫀⚡️Trace ischemia-arrhythmia link?🩺#Cardiology #Anatomy #MedEd #ECG #Electrophysiology
Palpitations affect 6% to 11% of the general population, but standard 24-hour Holter monitors often miss them, offering a diagnostic yield as low as 10% to 15%. 🫀 Can our smartwatches bridge this gap? ⌚ The WATCHinTIME study explored exactly this! 🧵👇
1
22
The Takeaway 💡 When used by symptomatic, educated patients, smartwatch ECGs provide a high diagnostic yield for a broad spectrum of arrhythmias, extending far beyond just atrial fibrillation. Wearable technology is ready to effectively complement traditional cardiology tools! 🚀
1
7
🫀 A unique EP case! We documented the case of a double QRS transition due to anodal capture during Left Bundle Branch Area Pacing (LBBAP). Here’s why device optimization is a unique challenge in this emerging approach 🧵👇.
1
44
THE CLINICAL TAKEAWAY: When using LBBAP in complex hybrid configurations (like with an RV defibrillation lead), high pacing outputs can inadvertently cause RV-only pacing, entirely subverting the physiological benefits of CSP. Careful multi-vector optimization is critical!
1
25
Read the full open-access case report here: doi.org/10.3390/jcdd12080299.
7
Angelo Melpignano retweeted
New #ESCStrokeBlog
🎯Evolocumab and the New Era of Cardiovascular Prevention
Check out! tinyurl.com/yx952eyc
#cholesterol #ldl #CVD
@Fra_Vitali90 @JacopoImberti @annapodlasek @L_Bergamaschi
